Compare PLUG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLUG | TMDX |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 1999 | 2019 |
| Metric | PLUG | TMDX |
|---|---|---|
| Price | $2.05 | $76.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $2.31 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 44.5M | 778.5K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.01 | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $709,919,000.00 | $605,494,000.00 |
| Revenue This Year | $26.67 | $24.25 |
| Revenue Next Year | $8.09 | $18.75 |
| P/E Ratio | ★ N/A | $378.73 |
| Revenue Growth | 12.90 | ★ 37.13 |
| 52 Week Low | $1.40 | $60.11 |
| 52 Week High | $4.58 | $156.00 |
| Indicator | PLUG | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 54.20 |
| Support Level | $1.92 | $64.87 |
| Resistance Level | $2.49 | $79.60 |
| Average True Range (ATR) | 0.14 | 3.15 |
| MACD | 0.01 | 0.46 |
| Stochastic Oscillator | 36.00 | 66.51 |
Plug Power Inc is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.